BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 15930332)

  • 1. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review.
    Singhal S; Vachani A; Antin-Ozerkis D; Kaiser LR; Albelda SM
    Clin Cancer Res; 2005 Jun; 11(11):3974-86. PubMed ID: 15930332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory remodeling of the microenvironment by abnormal type V collagen, apoptosis, and immune response in non-small cell lung cancer.
    Souza P; Rizzardi F; Noleto G; Atanazio M; Bianchi O; Parra ER; Teodoro WR; Carrasco S; Velosa AP; Fernezlian S; Ab'saber AM; Antonângelo L; Takagaki T; Schainberg CG; Yoshinari NH; Capelozzi VL
    Hum Pathol; 2010 Feb; 41(2):239-48. PubMed ID: 19828174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p21 and bcl-2 proteins in paraffin-embedded preparations of non-small cell lung cancer in stage IIIA after Etoposide and Cisplatin induced chemotherapy.
    Mańdziuk S; Dudzisz-Sledź M; Korszeń-Pilecka I; Milanowski J; Wojcierowski J; Korobowicz E
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):149-53. PubMed ID: 15314975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of prognostic significance of p21(WAF1/CIP1) protein expression in non-small cell lung cancer.
    Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; Jaśkiewicz K; Czestochowska E
    Acta Oncol; 2005; 44(1):75-9. PubMed ID: 15848909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication.
    Soria JC; Jang SJ; Khuri FR; Hassan K; Liu D; Hong WK; Mao L
    Cancer Res; 2000 Aug; 60(15):4000-4. PubMed ID: 10945597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
    Timotheadou E; Skarlos DV; Samantas E; Papadopoulos S; Murray S; Skrickova J; Christodoulou C; Papakostantinou C; Pectasides D; Papakostas P; Kaplanova J; Vrettou E; Karina M; Kosmidis P; Fountzilas G
    Anticancer Res; 2007; 27(6C):4481-9. PubMed ID: 18214064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
    Zhu ZH; Sun BY; Ma Y; Shao JY; Long H; Zhang X; Fu JH; Zhang LJ; Su XD; Wu QL; Ling P; Chen M; Xie ZM; Hu Y; Rong TH
    J Clin Oncol; 2009 Mar; 27(7):1091-9. PubMed ID: 19188679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.
    Takenaka K; Ishikawa S; Yanagihara K; Miyahara R; Hasegawa S; Otake Y; Morioka Y; Takahashi C; Noda M; Ito H; Wada H; Tanaka F
    Ann Surg Oncol; 2005 Oct; 12(10):817-24. PubMed ID: 16132376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
    Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
    Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras.
    Catzavelos C; Tsao MS; DeBoer G; Bhattacharya N; Shepherd FA; Slingerland JM
    Cancer Res; 1999 Feb; 59(3):684-8. PubMed ID: 9973218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
    Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
    Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
    Warnecke-Eberz U; Baldus SE; Bollschweiler E; Hoelscher AH; Metzger R
    Anticancer Res; 2008; 28(3A):1525-9. PubMed ID: 18630507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.
    Kim JS; Kim JW; Han J; Shim YM; Park J; Kim DH
    Cancer Res; 2006 Apr; 66(8):4049-54. PubMed ID: 16618724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
    Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
    Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
    In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 gene in stage IIIA non-small cell lung cancer in patients after neoadjuvant chemotherapy with Vepesid and Cisplatin.
    Mańdziuk S; Dudzisz-Sledź M; Korszeń-Pilecka I; Milanowski J; Wojcierowski J; Korobowicz E
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):154-7. PubMed ID: 15314976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors in stage I of non-small-cell bronchial carcinoma].
    Passlick B; Pantel K
    Zentralbl Chir; 1996; 121(10):851-7; discussion 858-60. PubMed ID: 9019934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.